Company Financials
IVERIC bio, Inc. Financials
Euro
business
IVERIC bio, Inc. Company Profile
Main Stock Listing
NASDAQ: ISEE
Market Capitalization $2.52 Billion as of Jan. 1, 2023
Market Cap History
Valuations Metrics as of Jan. 25, 2025
| Trailing PE | |
| Forward PE | |
| Price to Sales TTM | € |
| Price to Book MRQ | € |
| Enterprise to Revenue | |
| Enterprise to EBITDA |
Financial Reports as of
Financials
| Fiscal Year Ends | |
| Most Recent Quarter | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets TTM | % |
| Return on Equity TTM | % |
Income Statement
| Revenue TTM | €0 |
| Revenue per Share TTM | € |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | €0 |
| EBITDA | €0 |
| Net Income to Common TTM | €0 |
| Diluted EPS TTM | € |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | €0 |
| Total Cash per Share MRQ | € |
| Total Debt MRQ | € |
| Total Debt to Equity MRQ | |
| Current Ratio MRQ | |
| Book Value per Share MRQ | € |
Cash Flow
| Operating Cash Flow TTM | €0 |
| Levered Free Cash Flow TTM | €0 |
ISEE Stock Info as of Jan. 25, 2025
Stock Statistics
| Shares Outstanding | None |
| Float Shares | None |
| Avg 10 Volume | 500 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | % |
| % Held by Institutions | % |
Stock Price Summary
| Beta | |
| Fifty Two Week Low | €2.30 |
| Fifty Two Week High | €4.10 |
| Fifty Two Week Change | 25.64% |
| Day 50 MA | €3.47 |
| Day 200 MA | €2.92 |
Dividends and Splits
| Forward Annual Dividend Rate | €1.20 |
| Forward Annual Dividend Yield | 35.69% |
| Trailing Annual Dividend Rate | €0.30 |
| Trailing Annual Dividend Yield | 8.92% |
| Payout Ratio | % |
| Dividend Date | |
| Ex Dividend Date | 2024-11-13 |
| Last Split Factor | |
| Last Split Date |